DescriptionProductAvailABIlity:InStock(deliverywithin2-3businessdays,noextrachargefordrop-shipping).Ordering:ToplaceanorderviacreditcardorPOuseAddtoCartbutton(creatinganaccountisnotrequired).NANOPARTICLE-basedInVivoTransfectionKitsiRNAandplasmidDNAinvivodeliveryreagentModesofadmiNISTration:Systemicintravenous(i.v.)injectionDirectintratumoral(i.t.)injectionAltogen’s NANOPARTICLE InVivoTransfectionReagentNanoparticle-basedreagentComplexesarestableinserumfor16hEfficientdeliverytotheheart,lung,liver,pancreas,kidney,andmultipletumortypesviasystemicadministrationEfficientsiRNAandplasmidDNAdeliveryviadirectsubcutaneoustumorinjection(varioustumortypes)MinimaltoxicityFunctionallytestedinmiceApplicableforplasmidDNA/siRNAco-injectionDownloadNANOPARTICLE-basedinvivotransfectionprotocol:[PDF][Word]DownloadPowerPointpresentationforNANOPARTICLE-basedinvivotransfectionkit:[PPT]DevelopedandmanufacturedbyAltogenBiosystemsDATAFigure1.Systemicadministration(i.v.)ofNanoparticle-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).Figure2.Intratumoraladministration(i.t.)ofNanoparticle-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).Figure3. Systemicadministration(i.v.)ofNanoparticleInVivoTransfectionReagentconjugatedwith80ugofchemicallymodifiedsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.Tissues(Liver,Brain,Muscle,Kidney,Tumor,Heart,Spleen,Lung)werecollectedandtotalproteinfractionisolated72hoursafterfirstinjection.SampleswereanalyzedbyWesternBlotAnalysisforLaminA/Cgeneexpressionlevels.AllALTOGEN® INVIVO TransfectionKits suppliedwithready-to-runtransfectionprotocolsthateliminatetheneedforextensivetransfectionoptimizationexperiments. Readmore abouttransfectiontechnologyatAltogen’s TransfectionResource.NanoparticleTransfectionReagentcitationreferences:CardiovascularResearch.2016.110(1):30-39.Modulatorsofrightventricularapoptosisandcontractilityinaratmodelofpulmonaryhypertension.Zungu-Edmondsonetaletal[PDF]Hypertension2015.65(6):1307-15.Hypoxia-independentupregulationofplacentalhypoxiainducIBLefactor-1geneexpression…IriyamaTetal[PDF]Diabetologia.2015Aug;58(8):1949–1958.SilencingofmiR-195reducesdiabeticcardiomyopathyinC57BL/6mice.Zhengetal[PDF]JMolCellCardiol.2015Jan;0:174–185.Netrin-1AbrogatesIschemiaReperfusion-inducedCardiacMitochondrialDysfunctionviaNitricOxide-dependentAttenuationofNOX4ActivationandRecouplingofNOS.Siuetal[PDF]JCerebBloodFlowMetab.2017Jul;37(7):2359-2367.InhibitionofSrcfamilykinasesimprovescognitivefunctionafterintraventricularhemorrhageorintraventricularthrombin.Liuetal[PDF]NatureMedicine.201622,1131–1139.ThelongnoncodingRNAChaerdefinesanepigeneticcheckpointincardiachypertrophy.Wangetal[PDF]NatureBiotechnology.201129(4):341-5.DeliveryofsiRNAtothemousebrainby…Alvarez-Ervitietal [PDF]RequestaQuoteforNanoparticleInVivoTransfectionReagentAltogenResearchServices:AltogenLabsprovidesGLP-compliantcontractresearchstudiesforpre-clinicalresearch,INDapplications,anddrugdevelopment.OurBIOLOGyCROservices include:Xenograftservice(over60in-housevalidatedxenofraftmodels),developmentofstablecelllines,ELISAassaydevelopment,cell-basedandtissuetargetedRNAistudies,safetypharm/toxassays,andotherstudies(visitAltogenLabs.com).VolumeOptions:0.5ml–10injections(Catalog#5030)1.5ml–30injections(Catalog#5031)8.0ml–160injections(Catalog#5032)
Altogen Biosystems全国代理部分产品列表:
货号
|
产品
|
规格
|
价格(美元)
|
5030
|
|
|
|
1703
|
A204 Transfection Reagent (Rhabdomyosarcoma)
|
0.5ml
|
170
|
1704
|
A204 Transfection Reagent (Rhabdomyosarcoma)
|
1.5ml
|
348
窗体顶端
窗体底端
|
2101
|
A204 Transfection Reagent (Rhabdomyosarcoma)
|
1.5ml CRISPR
|
548
窗体顶端
窗体底端
|
7018
|
A204 Transfection Reagent (Rhabdomyosarcoma)
|
8.0ml
|
1044
窗体顶端
窗体底端
|
1167
|
A375 Cells Transfection Reagent (CRL-1619)
|
0.5ml
|
195
|
1168
|
A375 Cells Transfection Reagent (CRL-1620)
|
1.5ml
|
427
|
2102
|
A375 Cells Transfection Reagent (CRL-1621)
|
1.5ml CRISPR
|
627
|
1169
|
A375 Cells Transfection Reagent (CRL-1622)
|
8.0ml
|
1281
|
5030
|
Nanoparticle In Vivo Transfection Reagent
|
0.5 ml - 10 injections
|
445
|
5010
|
LIPID In Vivo Transfection Reagent
|
0.5 ml - 10 injections
|
405
|
5040
|
PEG-Liposome In Vivo Transfection Reagent
|
0.5 ml - 10 injections
|
465
|
5020
|
POLYMER In Vivo Transfection Reagent
|
0.5 ml - 10 injections
|
425
|
5050
|
Pancreas In Vivo Transfection Kit
|
0.5 ml - 10 injections
|
495
|
5060
|
Liver In Vivo Transfection Kit
|
0.5 ml - 10 injections
|
495
|
5070
|
Kidney In Vivo Transfection Kit
|
0.5 ml - 10 injections
|
495
|
1721
|
BMS2 Transfection Reagent (Bone Marrow Cells)
|
0.5 ml
|
231
|
6345
|
C6 Transfection Reagent (Glioma Cells, CCL-107)
|
0.5 ml
|
199
|
6803
|
DLD-1 Transfection Reagent (Colon Cancer, CCL-221)
|
0.5 ml
|
201
|
1775
|
HUH-7 Transfection Reagent (Liver Cancer Cells)
|
0.5 ml
|
179
|